The worst drug rule revisited: mathematical modeling of cyclic cancer treatments

DOI10.1007/s11538-010-9539-yzbMath1226.92037OpenAlexW2075672121WikidataQ46592038 ScholiaQ46592038MaRDI QIDQ644401

Allen A. Katouli, Natalia L. Komarova

Publication date: 4 November 2011

Published in: Bulletin of Mathematical Biology (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1007/s11538-010-9539-y

zbMATH Keywords

CMLstochastic modeling of cancer

Mathematics Subject Classification ID

Applications of branching processes (60J85) Medical applications (general) (92C50) Miscellaneous topics in calculus of variations and optimal control (49N99)

Related Items (5)

Optimal therapy scheduling based on a pair of collaterally sensitive drugs ⋮ Optimal policies of non-cross-resistant chemotherapy on Goldie and Coldman's cancer model ⋮ Modeling the role of altruism of antibiotic-resistant bacteria ⋮ A branching process model of heterogeneous DNA damages caused by radiotherapy in \textit{in vitro} cell cultures ⋮ On probabilistic certification of combined cancer therapies using strongly uncertain models

Cites Work

• Unnamed Item
• Unnamed Item
• The mathematical modelling of adjuvant chemotherapy scheduling: incorporating the effects of protocol rest phases and pharmacokinetics
• Selected topics in cancer modeling. Genesis, evolution, immune competition, and therapy
• A model for the resistance of tumor cells to cancer chemotherapeutic agents
• A branching-process model for heterogeneous cell populations
• A stochastic model for the origin and treatment of tumors containing drug-resistant cells
• The fixed-size Luria-Delbrück model with a nonzero death rate
• ON THE FOUNDATIONS OF CANCER MODELLING: SELECTED TOPICS, SPECULATIONS, AND PERSPECTIVES
• Cancer Modelling and Simulation
• Handbook of stochastic methods for physics, chemistry and the natural sciences.

This page was built for publication: The worst drug rule revisited: mathematical modeling of cyclic cancer treatments